Abstract: FR-PO953

Prevalence of Depression in Patients with ESRD on Hemodialysis and Peritoneal Dialysis in the West Area of Puerto Rico

Session Information

  • Patient Safety
    November 03, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Patient Safety

  • 1501 Patient Safety

Author

  • Mitchell, Sherryl Denisse, Baylor College of Medicine, Houston, Texas, United States
Background

Depressive symptoms and depression are major public health problems and the most frequent psychological problems reported among ESRD patients being treated by hemodialysis. We assessed the prevalence of depressive symptoms among hemodialysis and peritoneal dialysis patients at West area of Puerto Rico.
Despite these findings, depression may remain under recognized and undertreated, particularly among ESRD patients. A systematic assessment of depression in hemodialysis patients would supply information about patient feelings of well being. Existing data suggest that screening for depression may help identify patients at higher risk for death and hospitalization.

Methods

This cross-sectional study was represented with a sample of 146 hemodialysis patients selected from 3 dialysis centers of West Area at Puerto Rico. We provided written informed consent before filling questionnaires to patients.
The Beck Depression Inventory (BDI-II) is considered to be the standard instrument for assessing symptoms of depression and screening for clinical depression. We used this scale of 21 short answer question for assess degree of depression in studied patients.

Results

The prevalence of depression in peritoneal dialysis patients is 36% in our study when we compare the depression between HD and PD patients we noted that there is more prevalence of depression in Hemodialysis patients with a 53% than in the peritoneal group. There is significant effect between these groups (DF= 1, Value= 2.9849 and P-Value= 0.084) with a significance level at 10%.
For age ranges no significant effect was observed in depressive symptomatology (DF=1, P-value= 0.8453, Value=0.0381). In relation to the variable weather time in PD treatment and prevalence of depression there is not found significant differences (DF=2, P-value=0.8474, Value=0.3311).
More results to discuss further.

Conclusion

Based on our investigation the prevalence of depression is present in ESRD on PD and HD patients at West area of Puerto Rico. This supports the recommendations of early implementation psychological measures and medical treatment in an effort to influence the prognosis associated with the progression related morbidity/mortality and decrease hospitalization in ESRD on HD patients and improve quality of life!